2 news items
Cerus Corporation Announces First Quarter 2024 Financial Results
CERS
2 May 24
with its third party suppliers; Cerus' ability to identify and obtain additional partners to manufacture the INTERCEPT Blood System
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life
CERS
26 Mar 24
agency requirements, and (c) Cerus may be unable to maintain its supply agreements with its third party suppliers; risks associated with Cerus' need
- Prev
- 1
- Next